Selected Publications

Reshma Jagsi, Krithika Suresh, Chris D. Krenz, Rochelle Jones, Kent A Griffith, Lydia Perry, Sarah T. Hawley, Brian Zikmund-Fisher, Kayte Spector-Bagdady, Jodyn Platt, Raymond De Vries, Angela R. Bradbury, Pranshu Bansal, , Melissa Kaime, Monaliben Patel, Tracey Weisberg, Richard L. Schilsky, , Rebecca Spence.: Health Data Sharing Perspectives of Patients Receiving Care in CancerLinQ-Participating Oncology Practices JCO Oncol Pract : 2023 .

Dominique Fetzer, BA, Brian Egleston, PhD, Linda Fleisher, PhD, Lynne I Wagner, Phd, Kuang Yi-Wen, PhD, Sarah Brown, MS, LCGC, Cara Cacioppo, MS, LCGC, Dana Clark, MS, LCGC, Jessica Ebrahimzedeh, MS, LCGC, Sarah Howe, MS, LCGC, Kelsey Karpink, BS, Shelby Posen, BS, Enida Selmani, BS, Michelle Weinberg, MS, LCGC, Elisabeth Wood, MS, LCGC, Susan Domchek, MD, Angela Bradbury, MD.: Requests for provider mediated counseling and genetic testing choices among patients with metastatic cancer referred for genetic testing in the eReach Study. 17th International Meeting on Psychosocial Aspects of Hereditary Cancer, Bethesda, MD. : 2023.

Elisabeth Wood, Demetrios Ofidis, Lillian Phung, Rajia Mim, Brian Egleston, Sarah Howe, Lillian Hoffman-Andrews, Anjali Owens, Susan Domchek, Reed Pyeritz, Bryson Katona, Staci Kallish, Giorgio Sirugo, JoEllen Weaver, Katherine Nathanson, Dan Rader, Angela Bradbury.: Facilitating return of genetic research results from a biobank repository: participant uptake and utilization of digital interventions. 17th International Meeting on Psychosocial Aspects of Hereditary Cancer, Bethesda, MD. : 2023.

Bradbury AR, Kilbride M, Egleston BL, Domchek SM, Chung WK, Olopade O, Nathanson KL, Maxwell KN, Shah P, Churpek J, Fleisher L, Terry MB, Fetzer D, Brandt A, Clark D, Koval C, Long JM, McKenna D, Power J, Neilsen S and the RESPECT2 Research Team.: Evaluating disparities in uptake and outcomes with digital alternatives for pre-test education in return of cancer genetic research results. Symposium submission: Intervention strategies to facilitate access to cancer genetic services: Re-thinking approaches to mitigating disparities. 17th International Meeting on Psychosocial Aspects of Hereditary Cancer, Bethesda, MD. : 2023.

Jennings C, Wynn J, Miguel C, Levinson E, Florido ME, White M, Sands CB, Schwartz LA, Daly M, O'Toole K, Buys SS, Glendon G, Hanna D, Andrulis IL, Terry MB, Chung WK, Bradbury A.: Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk J Pediatr 1 : 113-119.e7,2022.

Makhlin I, McAndrew NP, Wileyto EP, Clark AS, Holmes R, Bottalico LN, Mesaros C, Blair IA, Jeschke GR, Fox KR, Domchek SM, Matro JM, Bradbury AR, Feldman MD, Hexner EO, Bromberg JF, DeMichele A.: Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer NPJ Breast Cancer 8 (1): 122,2022.

Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, Berger L, Blok MJ, Boonen SE, Borde J, Bradbury AR, Brunet J, Buys SS, Caligo MA, Campbell I, Chung WK, Claes KBM; GEMO Study Collaborators; EMBRACE Collaborators, Collonge-Rame MA, Cook J, Cosgrove C, Couch FJ, Daly MB, Dandiker S, Davidson R, de la Hoya M, de Putter R, Delnatte C, Dhawan M, Diez O, Ding YC, Domchek SM, Donaldson A, Eason J, Easton DF, Ehrencrona H, Engel C, Evans DG, Faust U, Feliubadaló L, Fostira F, Friedman E, Frone M, Frost D, Garber J, Gayther SA, Gehrig A, Gesta P, Godwin AK, Goldgar DE, Greene MH, Hahnen E, Hake CR, Hamann U, Hansen TVO, Hauke J, Hentschel J, Herold N, Honisch E, Hulick PJ, Imyanitov EN; SWE-BRCA Investigators; kConFab Investigators; HEBON Investigators, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James PA, Janavicius R, John EM, Joseph V, Karlan BY, Kemp Z, Kirk J, Konstantopoulou I, Koudijs M, Kwong A, Laitman Y, Lalloo F, Lasset C, Lautrup C, Lazaro C, Legrand C, Leslie G, Lesueur F, Mai PL, Manoukian S, Mari V, Martens JWM, et al.: Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers Commun Biol 5 (1): 1061,2022.

Houghton LC, Wei Y, Wang T, Goldberg M, Paniagua-Avila A, Sweeden RL, Bradbury A, Daly M, Schwartz LA, Keegan T, John EM, Knight JA, Andrulis IL, Buys SS, Frost CJ, O'Toole K, White ML, Chung WK, Terry MB.: Body mass index rebound and pubertal timing in girls with and without a family history of breast cancer: the LEGACY girls study Int J Epidemiol 51 (5): 1546-1555,2022.

Madison K Kilbride, Angela R Bradbury.: Consumers’ Perspectives Following Direct-to-Consumer Genetic Testing for Cancer Risk ELSIcon Annual Meeting, New York, NY. : 2022.

Goldberg M, McDonald JA, Houghton LC, Andrulis IL, Knight JA, Bradbury AR, Schwartz LA, Buys SS, Frost CJ, Daly MB, John EM, Keegan THM, Chung WK, Wei Y, Terry MB.: Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk Int J Epidemiol 52 (1): 272-283,2022.

Academic Contact Information

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-106
3400 Civic Center Boulevard
Philadelphia, PA 19104
Phone: 215-615-3360
Patient appointments: 800-789-7366